Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism

Abstract Context The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical endocrinology and metabolism 2017-09, Vol.102 (9), p.3085-3090
Hauptverfasser: Aycan, Zehra, Cangul, Hakan, Muzza, Marina, Bas, Veysel N, Fugazzola, Laura, Chatterjee, V Krishna, Persani, Luca, Schoenmakers, Nadia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3090
container_issue 9
container_start_page 3085
container_title The journal of clinical endocrinology and metabolism
container_volume 102
creator Aycan, Zehra
Cangul, Hakan
Muzza, Marina
Bas, Veysel N
Fugazzola, Laura
Chatterjee, V Krishna
Persani, Luca
Schoenmakers, Nadia
description Abstract Context The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. Case Description We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin >100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred. Conclusion This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH. Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH.
doi_str_mv 10.1210/jc.2017-00529
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5587079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1210/jc.2017-00529</oup_id><sourcerecordid>1970003574</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4919-a0f524f675558803d101b2e377283a9a62242f7b6d74f06d4afb7ea0760932483</originalsourceid><addsrcrecordid>eNp9kM1P3DAUxK2qVdlCj1xRpF64mD5_xfEFqVpoQaLiAio3y5s4xNtsvLUd0P73ddgFtUjtyfbzb-aNBqFDAieEEvi8rE8oEIkBBFVv0IwoLrAkSr5FMwBKsJL0bg99iHEJQDgX7D3ao1XJmAA5Q5dn7t4Ori7Obq_vSGGG5ulGi-9jMsn5IRZuKOYm2lj8cKkr5n6YBMn0xcVm7VO3Cd41Lq4O0LvW9NF-3J376Pbr-c38Al9df7ucf7nCNVdEYQOtoLwtpRCiqoA1BMiCWiYlrZhRpqSU01YuykbyFsqGm3YhrQFZgmKUV2wfnW591-NiZZvaDimYXq-DW5mw0d44_ffP4Dp97x903idBqmzwaWcQ_K_RxqSXfgxDzqxzbQDAhOSZwluqDj7GYNuXDQT01Lxe1npqXj81n_mjP2O90M9VZ4BsgUffJxviz358tEF31vSpe22Kn035fzQ5KvBSVnhSgMovPI1Ilh1vZX5c_yv2bsNvdAqoTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1970003574</pqid></control><display><type>article</type><title>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</title><source>ProQuest One Community College</source><source>MEDLINE</source><source>ProQuest Central (Alumni Edition)</source><source>Journals@Ovid Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><source>ProQuest Central</source><creator>Aycan, Zehra ; Cangul, Hakan ; Muzza, Marina ; Bas, Veysel N ; Fugazzola, Laura ; Chatterjee, V Krishna ; Persani, Luca ; Schoenmakers, Nadia</creator><creatorcontrib>Aycan, Zehra ; Cangul, Hakan ; Muzza, Marina ; Bas, Veysel N ; Fugazzola, Laura ; Chatterjee, V Krishna ; Persani, Luca ; Schoenmakers, Nadia</creatorcontrib><description>Abstract Context The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. Case Description We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin &gt;100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) &lt;0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G&gt;C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred. Conclusion This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH. Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2017-00529</identifier><identifier>PMID: 28633507</identifier><language>eng</language><publisher>Washington, DC: Endocrine Society</publisher><subject>Biosynthesis ; Case Reports ; Chemical reactions ; Codon, Nonsense ; Cohort Studies ; Congenital diseases ; Congenital Hypothyroidism - diagnosis ; Congenital Hypothyroidism - genetics ; Dual Oxidases ; Environmental factors ; Female ; Genetic Predisposition to Disease ; Genetic Variation ; Genotype ; Homology ; Humans ; Hydrogen peroxide ; Hypothyroidism ; Infant ; Infant, Newborn ; Iodide peroxidase ; Iodination ; Iodine ; Male ; Mutation ; NAD ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Nonsense mutation ; Pedigree ; Peroxidase ; Phenotype ; Phosphates ; Retrospective Studies ; Severity of Illness Index ; Siblings ; Splicing ; Thyroid ; Thyroid Function Tests ; Thyroid gland ; Thyroid-stimulating hormone ; Thyroxine</subject><ispartof>The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3085-3090</ispartof><rights>Copyright © Oxford University Press 2015</rights><rights>Copyright © 2017 Endocrine Society</rights><rights>Copyright © Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4919-a0f524f675558803d101b2e377283a9a62242f7b6d74f06d4afb7ea0760932483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1970003574?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,315,781,785,886,21393,21394,27929,27930,33535,33749,43664,43810,64390,64394,72474,73133,73134,73136</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28633507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aycan, Zehra</creatorcontrib><creatorcontrib>Cangul, Hakan</creatorcontrib><creatorcontrib>Muzza, Marina</creatorcontrib><creatorcontrib>Bas, Veysel N</creatorcontrib><creatorcontrib>Fugazzola, Laura</creatorcontrib><creatorcontrib>Chatterjee, V Krishna</creatorcontrib><creatorcontrib>Persani, Luca</creatorcontrib><creatorcontrib>Schoenmakers, Nadia</creatorcontrib><title>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Abstract Context The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. Case Description We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin &gt;100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) &lt;0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G&gt;C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred. Conclusion This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH. Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH.</description><subject>Biosynthesis</subject><subject>Case Reports</subject><subject>Chemical reactions</subject><subject>Codon, Nonsense</subject><subject>Cohort Studies</subject><subject>Congenital diseases</subject><subject>Congenital Hypothyroidism - diagnosis</subject><subject>Congenital Hypothyroidism - genetics</subject><subject>Dual Oxidases</subject><subject>Environmental factors</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Variation</subject><subject>Genotype</subject><subject>Homology</subject><subject>Humans</subject><subject>Hydrogen peroxide</subject><subject>Hypothyroidism</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Iodide peroxidase</subject><subject>Iodination</subject><subject>Iodine</subject><subject>Male</subject><subject>Mutation</subject><subject>NAD</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Nonsense mutation</subject><subject>Pedigree</subject><subject>Peroxidase</subject><subject>Phenotype</subject><subject>Phosphates</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Siblings</subject><subject>Splicing</subject><subject>Thyroid</subject><subject>Thyroid Function Tests</subject><subject>Thyroid gland</subject><subject>Thyroid-stimulating hormone</subject><subject>Thyroxine</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kM1P3DAUxK2qVdlCj1xRpF64mD5_xfEFqVpoQaLiAio3y5s4xNtsvLUd0P73ddgFtUjtyfbzb-aNBqFDAieEEvi8rE8oEIkBBFVv0IwoLrAkSr5FMwBKsJL0bg99iHEJQDgX7D3ao1XJmAA5Q5dn7t4Ori7Obq_vSGGG5ulGi-9jMsn5IRZuKOYm2lj8cKkr5n6YBMn0xcVm7VO3Cd41Lq4O0LvW9NF-3J376Pbr-c38Al9df7ucf7nCNVdEYQOtoLwtpRCiqoA1BMiCWiYlrZhRpqSU01YuykbyFsqGm3YhrQFZgmKUV2wfnW591-NiZZvaDimYXq-DW5mw0d44_ffP4Dp97x903idBqmzwaWcQ_K_RxqSXfgxDzqxzbQDAhOSZwluqDj7GYNuXDQT01Lxe1npqXj81n_mjP2O90M9VZ4BsgUffJxviz358tEF31vSpe22Kn035fzQ5KvBSVnhSgMovPI1Ilh1vZX5c_yv2bsNvdAqoTA</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Aycan, Zehra</creator><creator>Cangul, Hakan</creator><creator>Muzza, Marina</creator><creator>Bas, Veysel N</creator><creator>Fugazzola, Laura</creator><creator>Chatterjee, V Krishna</creator><creator>Persani, Luca</creator><creator>Schoenmakers, Nadia</creator><general>Endocrine Society</general><general>Copyright Oxford University Press</general><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>201709</creationdate><title>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</title><author>Aycan, Zehra ; Cangul, Hakan ; Muzza, Marina ; Bas, Veysel N ; Fugazzola, Laura ; Chatterjee, V Krishna ; Persani, Luca ; Schoenmakers, Nadia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4919-a0f524f675558803d101b2e377283a9a62242f7b6d74f06d4afb7ea0760932483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biosynthesis</topic><topic>Case Reports</topic><topic>Chemical reactions</topic><topic>Codon, Nonsense</topic><topic>Cohort Studies</topic><topic>Congenital diseases</topic><topic>Congenital Hypothyroidism - diagnosis</topic><topic>Congenital Hypothyroidism - genetics</topic><topic>Dual Oxidases</topic><topic>Environmental factors</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Variation</topic><topic>Genotype</topic><topic>Homology</topic><topic>Humans</topic><topic>Hydrogen peroxide</topic><topic>Hypothyroidism</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Iodide peroxidase</topic><topic>Iodination</topic><topic>Iodine</topic><topic>Male</topic><topic>Mutation</topic><topic>NAD</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Nonsense mutation</topic><topic>Pedigree</topic><topic>Peroxidase</topic><topic>Phenotype</topic><topic>Phosphates</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Siblings</topic><topic>Splicing</topic><topic>Thyroid</topic><topic>Thyroid Function Tests</topic><topic>Thyroid gland</topic><topic>Thyroid-stimulating hormone</topic><topic>Thyroxine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aycan, Zehra</creatorcontrib><creatorcontrib>Cangul, Hakan</creatorcontrib><creatorcontrib>Muzza, Marina</creatorcontrib><creatorcontrib>Bas, Veysel N</creatorcontrib><creatorcontrib>Fugazzola, Laura</creatorcontrib><creatorcontrib>Chatterjee, V Krishna</creatorcontrib><creatorcontrib>Persani, Luca</creatorcontrib><creatorcontrib>Schoenmakers, Nadia</creatorcontrib><collection>Access via Oxford University Press (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aycan, Zehra</au><au>Cangul, Hakan</au><au>Muzza, Marina</au><au>Bas, Veysel N</au><au>Fugazzola, Laura</au><au>Chatterjee, V Krishna</au><au>Persani, Luca</au><au>Schoenmakers, Nadia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2017-09</date><risdate>2017</risdate><volume>102</volume><issue>9</issue><spage>3085</spage><epage>3090</epage><pages>3085-3090</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Abstract Context The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase–catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. Case Description We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434*); P1, P2: thyrotropin &gt;100 µU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) &lt;0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G&gt;C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs*43), which segregates with CH in this kindred. Conclusion This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH. Whole-exome sequencing in siblings with a known homozygous DUOX2 mutation and unusually marked congenital hypothyroidism (CH) identified the human homozygous DUOX1 mutation, segregating with CH.</abstract><cop>Washington, DC</cop><pub>Endocrine Society</pub><pmid>28633507</pmid><doi>10.1210/jc.2017-00529</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The journal of clinical endocrinology and metabolism, 2017-09, Vol.102 (9), p.3085-3090
issn 0021-972X
1945-7197
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5587079
source ProQuest One Community College; MEDLINE; ProQuest Central (Alumni Edition); Journals@Ovid Complete; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection; ProQuest Central
subjects Biosynthesis
Case Reports
Chemical reactions
Codon, Nonsense
Cohort Studies
Congenital diseases
Congenital Hypothyroidism - diagnosis
Congenital Hypothyroidism - genetics
Dual Oxidases
Environmental factors
Female
Genetic Predisposition to Disease
Genetic Variation
Genotype
Homology
Humans
Hydrogen peroxide
Hypothyroidism
Infant
Infant, Newborn
Iodide peroxidase
Iodination
Iodine
Male
Mutation
NAD
NADPH Oxidases - genetics
NADPH Oxidases - metabolism
Nonsense mutation
Pedigree
Peroxidase
Phenotype
Phosphates
Retrospective Studies
Severity of Illness Index
Siblings
Splicing
Thyroid
Thyroid Function Tests
Thyroid gland
Thyroid-stimulating hormone
Thyroxine
title Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T07%3A24%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Digenic%20DUOX1%20and%20DUOX2%20Mutations%20in%20Cases%20With%20Congenital%20Hypothyroidism&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Aycan,%20Zehra&rft.date=2017-09&rft.volume=102&rft.issue=9&rft.spage=3085&rft.epage=3090&rft.pages=3085-3090&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/jc.2017-00529&rft_dat=%3Cproquest_pubme%3E1970003574%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1970003574&rft_id=info:pmid/28633507&rft_oup_id=10.1210/jc.2017-00529&rfr_iscdi=true